Dossier
Daniel Domenico
Coverage of Daniel Domenico in the Nexus archive.
- A pharmaceutical company is trying to block Colorado’s first-in-the-nation drug price cap in court
A pharmaceutical company is challenging Colorado's first-in-the-nation price cap on a brand-name drug in court. Colorado's Prescription Drug Affordability Board (PDAB) set a cap on the drug Enbrel after determining it was unaffordable, prompting a lawsuit from Amgen. A judge is considering whether to issue a temporary injunction to block the cap while the case proceeds.